A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma

Ignace B. Vergote, David C. Smith, Raanan Berger, Razelle Kurzrock, Nicholas J. Vogelzang, Avishay Sella, Jennifer Wheler, Yihua Lee, Paul G. Foster, Ron Weitzman, Ronald J. Buckanovich

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science